Live Breaking News & Updates on Global Clinical Trial|Page 3

Stay updated with breaking news from Global clinical trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Covid-19, flu combo vaccines an advance but with distribution quandaries

Experts were less keen on variant-specific vaccines versus Covid-19/flu combo due to lack of practical value, despite scientific rationale. ....

United Kingdom , United States , Beta Delta , Alpha Delta , Novavax Covid , Sanofi Fluzone , John Mccauley , Novavax Nanoflu , William Schaffner , Rodney Rhode , Reynold Panettieri Jr , Contract Research Organisation For Clinical Trials , Vanderbilt University , United Kingdom Health Security Agency , Francis Crick Institute , Rutgers Institute For Translational Medicine , Worldwide Influenza Centre , Clinical Laboratory Science Program , Texas State , Vice Chancellor , Rutgers Institute , Translational Medicine , Francis Crick , Health Security , Key Challenges , Global Clinical Trial ,

Equillium begins Phase III acute graft-versus-host disease therapy trial

Equillium has commenced the Phase III EQUATOR clinical trial of itolizumab to treat acute graft-versus-host disease (aGVHD) patients. ....

Saas Platform Decentralizing Clinical Research At Scale , Eu Open Market Solutions For Clinical Trials , Market Solutions , Key Challenges , Global Clinical Trial ,

Ukraine: Ex-FDAer calls for agency to stop Russian regulatory reviews

"I think it’s a terrible idea if the FDA would keep processing Russia entities’ pitches to enter the US market.” ....

Saint Petersburg , Sankt Peterburg , Petrovax Pharm , Joe Biden , Time Data Services For Clinical Research , Saint Petersburg State University , Office Of Orphan Products Development , Radiologic Health , Stim Cot , Clinical Trials , Clinical Trials Arena , Drugs Evaluation , Biologics Evaluation , Orphan Products , Only Orphans Cot , Time Data Services , Clinical Research , Cost Effective Preclinical Cancer Model Searches , Key Challenges , Global Clinical Trial ,

Maze Therapeutics initiates dosing in Phase I Pompe disease therapy trial

Maze has commenced participant dosing in its Phase I clinical trial of oral glycogen synthase (GYS1) inhibitor, MZE001, to treat Pompe diseas ....

Sarah Noonberg , Life Sciences Companies , Translation Services For , Maze Therapeutics , Cellular Immune , Life Sciences , Key Challenges , Global Clinical Trial ,

Pardes reports interim data from Phase I trial of oral Covid-19 antiviral

Pardes Biosciences has reported interim results from the Phase I trial of its oral antiviral drug, PBI-0451, in healthy adult subjects. ....

New Zealand , Pardes Biosciences , Drug Administration , Parde Investigational New Drug , Preference Management Solution , Key Challenges , Global Clinical Trial ,